Oak Associates’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.32M Hold
4,383
0.13% 80
2026
Q1
$2.1M Hold
4,383
0.14% 79
2025
Q4
$2.46M Sell
4,383
-88
-2% -$50K 0.15% 66
2025
Q3
$2.3M Hold
4,471
0.14% 69
2025
Q2
$1.4M Hold
4,471
0.09% 84
2025
Q1
$1.36M Buy
+4,471
New +$1.5M 0.1% 90
2022
Q3
Sell
-11,296
Closed -$1.69M 134
2022
Q2
$1.69M Buy
11,296
+3,199
+40% +$463K 0.13% 81
2022
Q1
$1.32M Hold
8,097
0.08% 98
2021
Q4
$1.76M Buy
+8,097
New +$1.7M 0.09% 91

Other funds holding MEDP

Oak Associates's MEDP Position: Q2 2026 in Review

Oak Associates held its Medpace (MEDP) position steady in Q2 2026 at 4,383 shares worth $2.32M. The position accounts for 0.13% of the portfolio, ranked #80.

Oak Associates first reported a position in MEDP in Q4 2021 and has held it in 9 quarters since. The position peaked at $2.46M in Q4 2025. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Oak Associates held 4,383 shares of Medpace worth $2.32M as of Q2 2026.
  • Oak Associates left its Medpace share count unchanged in Q2 2026.
  • Medpace made up 0.13% of Oak Associates's portfolio in Q2 2026, its #80 holding.
  • Oak Associates first reported a position in Medpace in Q4 2021 and has held it in 9 quarters since.
  • Oak Associates's Medpace position peaked at $2.46M in Q4 2025.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Oak Associates's 13F filing for Q2 2026, filed 14 Aug 2026.